Increased risk during winter: common respiratory viruses and clinical outcomes in hospitalized children

Furkan Kalayci1, Aslinur Ozkaya Parlakay2, Metin Yigit3

  • 1Department of Pediatrics, Ankara Bilkent City Hospital, Bilkent, Ankara, 06800, Turkey. drfurkankalayci@gmail.com.

PubMed

Insights

This study analyzed 1465 children hospitalized with acute respiratory infections (ARIs). Human bocavirus (hBoV) and influenza virus (IFV) were common, with hBoV linked to higher intensive care needs and mortality, especially in children with chronic conditions.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Public Health

Background:

  • Acute respiratory infections (ARIs) are a major cause of childhood hospitalization, morbidity, and mortality globally.
  • Common viral pathogens contributing to ARIs include influenza virus (IFV), human bocavirus (hBoV), human metapneumovirus (hMPV), human rhinovirus (hRV), and human respiratory syncytial virus (hRSV).

Purpose of the Study:

  • To evaluate the clinical features, laboratory findings, and outcomes of pediatric patients hospitalized with ARIs caused by common respiratory viruses.
  • To identify specific viral pathogens and their association with disease severity and patient characteristics.

Main Methods:

  • A retrospective analysis of 1465 pediatric patients hospitalized with ARIs between August 2019 and March 2024.
  • Multiplex real-time PCR was used to identify viral pathogens from nasopharyngeal swabs.
  • Clinical data, including demographics, comorbidities, intensive care unit (ICU) admission, and respiratory support, were reviewed.

Main Results:

  • Influenza virus (IFV) was detected in 30.1% of cases, human bocavirus (hBoV) in 28.3%, human respiratory syncytial virus (hRSV) in 18.4%, human rhinovirus (hRV) in 14.4%, and human metapneumovirus (hMPV) in 8.8%.
  • hBoV and hRSV infections were associated with increased need for intensive care and invasive mechanical ventilation, particularly in patients with chronic health conditions.
  • The overall mortality rate was 8.7%, with hBoV demonstrating the highest association with mortality, especially in children with underlying chronic conditions.

Conclusions:

  • Viral ARIs in hospitalized children are frequently caused by IFV, hBoV, hRSV, hRV, and hMPV, with a higher incidence during winter months.
  • hBoV and IFV infections warrant close monitoring in children with chronic health conditions due to increased risk.
  • Meticulous management of hBoV and hRSV infections is crucial due to their association with severe outcomes and increased need for intensive care support.
Abstract

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
137
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
129
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
145
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
151
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
107
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
264